Bridge to Life Showcases VitaSmart HOPE Data at ATC 2026
DULUTH, Ga., June 23, 2026 Bridge to Life Ltd. announced new investigator-initiated research presented at the 2026 American Transplant...
organ preservation
Advertisement
Bridge to Life’s VitaSmart HOPE Boosts Liver Transplant Success
DULUTH, Georgia, May 28, 2026 Bridge to Life™ Ltd. has announced the publication of landmark clinical trial results in...
FDA Grants IDE Approval for OCS Heart ENHANCE Trial
Andover, Massachusetts | February 9, 2026 — TransMedics Group has received full and unconditional Investigational Device Exemption (IDE) approval...
OrganOx–Terumo Deal Ushers in New Era of Organ Preservation Science
Oxford, England, and Madison, New Jersey, October 30, 2025 — Terumo Corporation, a global leader in medical technology, has...
FDA Clears Bridge to Life Organ Preservation Solutions
DULUTH, Ga., Oct. 7, 2025 — Bridge to Life Ltd. has received FDA 510(k) clearance for its multi-sourced Belzer...
Advertisement
